AbCellera Biologics Inc. (ABCL) Fundamentals

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
SHARE INFORMATION
Market Cap$ 3,635,517,698
Shares Outstanding285,138,643
Float152,185,070
Percent Float53.37%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 375,223,000
Latest Fiscal EPS$ 0.47
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions278
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months18,063,882
Institutional Holdings Percent69.6%
Institutional Sold Previous 3 Months40,676,787
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months2,178,226
Insider Holdings Percent1.2
Insider Sold Previous 3 Months56,125
Insider Shares Owned3,305,484
TRADING INFO
52 Week High$ 22.63
52 Week Low$ 5.42
52 Week High Change$ -27.80
21 Day Moving Average$ 11.2926
21 Day Extended Moving Average$ 11.7089
50 Day Moving Average$ 10.5231
50 Day Extended Moving Average$ 10.7142
200 Day Moving Average$ 10.6211
200 Day Extended Moving Average$ 12.0225
10 Day Average Volume2,744,584
20 Day Average Volume2,120,727
30 Day Average Volume2,033,579
50 Day Average Volume2,917,194
Alpha-0.042592
Beta-1.1309
Standard Deviation0.207920
R20.071725
7 Day Price Change$ 1.64
7 Day Percent Change14.76%
21 Day Price Change$ 2.56
21 Day Percent Change25.12%
30 Day Price Change$ 2.21
30 Day Percent Change20.97%
Month to Date Price Change$ 2.71
Month to Date Percent Change26.99%
Quarter to Date Price Change$ 2.10
Quarter to Date Percent Change19.72%
180 Day Price Change$ 2.95
180 Day Percent Change30.1%
200 Day Price Change$ 4.16
200 Day Percent Change48.43%
Year to Date Price Change$ -1.55
Year to Date Percent Change-10.84%

AbCellera Biologics Inc. (ABCL) Key Ratios

PROFITABILITY
EBIT Margin56.9%
EBITDA Margin60.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count39.39%
Gross Margin85.9%
Profit Margin TOT39.39%
INCOME STATEMENTS
Revenue$ 507,337,000
Revenue Per Share$ 1.7793
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.80
Total Debt To Equity0.00
Int Coverage59.90
Current Ratio5.20
Leverage Ratio1.30
Quick Ratio4.90
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio21.50
Enterprise Value$ 2,875,292,226
Price to Sales7.1659
Price to Free Cash15.50
PE High Last 5 Years0.00
Price To Book3.20
Price To Cash Flow12.10
PE Low Last 5 Years0.00
Price to Tangible Book3.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.10
Invoice Turnover127.60
Assets Turnover0.40
Return Assets15.34
Return on Equity19.38
Return on Capital17.80

AbCellera Biologics Inc. (ABCL) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOCarl L.G. Hansen
Emplyoees386
Last AuditUQ
CIK0001703057
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address2215 Yukon Street
Vancouver, BC V5Y 0A1
Websitehttps://www.abcellera.com
Facsimile-
Telephone+1 604 559-9005
Emailinfo@abcellera.com


Your Recent History
NASDAQ
ABCL
AbCellera ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.